Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia

被引:3
|
作者
Nash, Emily [1 ,2 ]
Nicoll, Amanda [3 ]
Batt, Nicholas [3 ]
George, Jacob [4 ,5 ]
Perananthan, Varan [6 ]
Prince, David [7 ,8 ]
Wallace, Michael [9 ,10 ]
Gow, Paul [11 ]
Vaz, Karl [11 ]
Chitturi, Shivakumar [12 ]
Flores, Joan Ericka [12 ]
Braund, Alicia [13 ]
Bonnichsen, Mark [7 ]
Riordan, Stephen [14 ]
Humphris, Jeremy [15 ]
Duong, Tuan [15 ]
Mckenzie, Catriona [16 ]
Liu, Ken [1 ,2 ]
Strasser, Simone I. [1 ,2 ]
机构
[1] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Missenden Rd, Sydney, NSW, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[3] Eastern Hlth, Melbourne, Vic, Australia
[4] Westmead Hosp, Westmead Millennium Inst, Storr Liver Ctr, Westmead, NSW, Australia
[5] Univ Sydney, Sydney, NSW, Australia
[6] Westmead Hosp, Dept Gastroenterol & Hepatol, Westmead, NSW, Australia
[7] Liverpool Hosp, Dept Gastroenterol & Liver, Sydney, NSW, Australia
[8] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[9] Sir Charles Gairdner Hosp, Perth, WA, Australia
[10] Univ Western Australia, Med Sch, Perth, WA, Australia
[11] Austin Hlth, Melbourne, Vic, Australia
[12] Canberra Hosp, Canberra, ACT, Australia
[13] Gold Coast Univ Hosp, Gold Coast, Qld, Australia
[14] Prince Wales Hosp, Sydney, NSW, Australia
[15] Wollongong Hosp, Wollongong, NSW, Australia
[16] NSW Hlth Pathol, Sydney, NSW, Australia
关键词
PHENOTYPE; SAFETY;
D O I
10.1111/apt.17906
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundReports of DILI due to herbal and dietary supplements have been increasing over time.AimsTo characterise clinical, laboratory and histopathological phenotypes and outcomes of drug-induced liver injury (DILI) due to anabolic-androgenic steroids (AAS), selective androgen receptor modulators (SARMs), and bodybuilding supplements (BBS) in Australia.MethodsRetrospective case series. Patients presented to nine Australian tertiary hospitals, 2017-2023. DILI was defined biochemically and patients were included if their treating physician attributed DILI to preceding use of AAS, SARMs or BBS. Primary endpoint was time to normalisation of liver biochemistry. Secondary endpoints were hospitalisation for investigation or management of DILI, death attributable to liver injury, and liver transplantation.ResultsTwenty-three cases of DILI were identified, involving 40 drugs: 18 AAS, 14 SARMs and eight BBS. Patients were predominantly male (22/23), with median age 30 years (IQR 26-42). Most were symptomatic (21/23). Median latency of onset was 58 days (IQR 28-112 days) from drug commencement. Most patients (17/23) were admitted to hospital. Based on updated Roussel Uclaf Causality Assessment Method, DILI was possible in 17/23, probable in 2/23 and unlikely in 4/23. Median time to normalisation of liver biochemistry was 175 days (IQR 70-292 days) from presentation. Three (3/23) were treated with corticosteroids, 14/23 were treated for itch, and one (1/23) underwent liver transplantation. There were no deaths.ConclusionsThe prognosis of DILI from AAS, SARMs and BBS is good although liver transplantation may rarely be required. A detailed drug history is important in uncovering DILI due to these supplements. Liver injury is an important consideration of these drugs. Prognosis with supportive care is good, with normalisation of liver biochemistry the most likely outcome, although hospitalisation may be required and, rarely, liver transplantation. A detailed drug and dietary supplement history is important in elucidating causes of DILI.image
引用
收藏
页码:953 / 961
页数:9
相关论文
共 50 条
  • [31] Drug-induced Liver Injury Associated with Weight Loss Supplements
    James Walter
    Victor Navarro
    Simona Rossi
    Current Hepatology Reports, 2018, 17 (3) : 245 - 253
  • [32] Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
    Bhasin, S
    Calof, OM
    Storer, TW
    Lee, ML
    Mazer, NA
    Jasuja, R
    Montori, VM
    Gao, WQ
    Dalton, JT
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (03): : 146 - 159
  • [33] Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
    Shalender Bhasin
    Olga M Calof
    Thomas W Storer
    Martin L Lee
    Norman A Mazer
    Ravi Jasuja
    Victor M Montori
    Wenqing Gao
    James T Dalton
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 146 - 159
  • [34] Treatment of Idiosyncratic Drug-Induced Liver Injury Using Steroids
    Sundaram, Suneha
    Vuppalanchi, Raj
    Saxena, Romil
    Chalasani, Naga
    ACG CASE REPORTS JOURNAL, 2020, 7 (02)
  • [35] ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
    Medina-Caliz, I.
    Gonzalez-Jimenez, A.
    Robles-Diaz, M.
    Stephens, C.
    Cabello, M.
    Garcia-Munoz, B.
    Garcia-Cortes, M.
    Alcantara, R.
    Gonzalez-Grande, R.
    Jimenez, M.
    Rendon, P.
    Navarro, J. M.
    Mendez, I. M.
    Bessone, F.
    Gines, P.
    Alfaro, I.
    Brahm, J. R.
    Parana, R.
    Schinoni, M. I.
    Prieto, M.
    Garcia-Eliz, M.
    Romero-Gomez, M.
    Calle-Sanz, R.
    Gonzalez-Ramirez, A. F.
    Crespillo, A.
    Lucena, M. I.
    Andrade, R. J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S169 - S169
  • [36] Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review
    Machek, Steven B.
    Cardaci, Thomas D.
    Wilburn, Dylan T.
    Willoughby, Darryn S.
    STEROIDS, 2020, 164
  • [37] Turmeric's Bitter Twist: Drug-Induced Liver Injury from Turmeric Supplements
    Jalalian, Aria
    Gallagher, Stefanie
    Spitofsky, Nina R.
    Huang, Andy
    Fink, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2890 - S2890
  • [38] Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
    Natalia Leciejewska
    Karol Jędrejko
    Víctor M. Gómez-Renaud
    Josué Manríquez-Núñez
    Bożena Muszyńska
    Andrzej Pokrywka
    European Journal of Clinical Pharmacology, 2024, 80 : 185 - 202
  • [39] Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases
    Leciejewska, Natalia
    Jedrejko, Karol
    Gomez-Renaud, Victor M.
    Manriquez-Nunez, Josue
    Muszynska, Bozena
    Pokrywka, Andrzej
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (02) : 185 - 202
  • [40] Pregnane X receptor and drug-induced liver injury
    Wang, Yue-Ming
    Chai, Sergio C.
    Brewer, Christopher T.
    Chen, Taosheng
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (11) : 1521 - 1532